IOL Chemicals and Pharmaceuticals zooms on receiving patent from Government of India
Follow us Now on Telegram ! Get daily 10 - 12 important updates on Business, Finance and Investment. Join our Telegram Channel
https://t.me/InvestmentGuruIndiacom
Download Telegram App before Joining the Channel
IOL Chemicals And Pharmaceuticals is currently trading at Rs. 350.70, up by 19.95 points or 6.03% from its previous closing of Rs. 330.75 on the BSE.
The scrip opened at Rs. 331.05 and has touched a high and low of Rs. 356.20 and Rs. 331.05 respectively. So far 24788 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 536.70 on 07-Apr-2022 and a 52 week low of Rs. 295.10 on 08-Mar-2022.
Last one week high and low of the scrip stood at Rs. 356.20 and Rs. 316.25 respectively. The current market cap of the company is Rs. 2079.35 crore.
The promoters holding in the company stood at 43.69%, while Institutions and Non-Institutions held 2.46% and 53.83% respectively.
IOL Chemicals and Pharmaceuticals has received patent for invention entitled an improved safe process for the preparation of Sartan Drugs of formula I from Controller of Patent, Indian Patent Office; Government of India.
Valsartan, Losartan, Irbesartan, Olmesartan, Candesartan and other Sartan drugs are a class of medicines known as angiotensin II receptor blocker (ARBs) used to treat high blood pressure and heart failure.
IOL Chemicals and Pharmaceuticals (IOLCP) is a leading organic chemicals manufacturers and suppliers.
